MPD no-action position, subject to certain specified conditions, on introducing broker and associated person registration for passive software providers.

Provides, subject to certain conditions, no-action positions for post-trade risk reduction service providers for failure to register as a swap execution facility, and for those entering into swaps that are subject to the swap clearing requirement and trade execution requirement.

MPD no-action position, subject to certain specified conditions, on introducing broker (IB) and associated person registration for a provider of self-custodial crypto asset wallet software that proposes to provide and market software to facilitate trading by its users with registered futures commission merchants and IBs and designated contract markets.

No-action position on commodity pool operator and commodity trading advisor registration for certain private funds and subject to certain conditions, with additional revision to address CPO delegation arrangements.

No-action position with respect to the exclusion of energy commodity end user swaps from the swap dealer de minimis calculation.

No-action position to UBS Europe SE in relation to statutory disqualification condition of CFTC Staff Letter No. 12-70 with respect to its affiliate support activities.

This letter serves to amend CFTC Letter No. 14-130, which permits Victoria University of Wellington, New Zealand (“Victoria University”) to operate a not-for-profit market for the trading of event contracts and the offering of such event contracts to U.S. persons (“the Market”). The Market has been operating under the trade name “PredictIt.” All terms of CFTC Letter 14-130 not amended by this letter shall remain in effect.

The Division of Market Oversight (“DMO”) of the Commodity Futures Trading Commission (“CFTC” or “Commission”) is hereby withdrawing CFTC Letter No. 21-19 – Staff Advisory on Swap Execution Facility Registration Requirement (the “SEF Registration Advisory”) in its entirety.

No-action position from CPO/CTA registration granted to an entity that uses foreign exchange swaps in managing the risks of its biopharmaceutical royalties business.

Extension of time-limited no-action relief for Shanghai Clearing House with regard to Section 5b(a) of the Commodity Exchange Act and Commission Regulations thereunder.